BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

524604

ADLINE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ADLINE CHEM LAB LIMITED Share Price Update

As of the latest trading session, ADLINE CHEM LAB LIMITED share price is currently at ₹ 12.82, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 12.82 and ₹ 12.82. Over the past year, ADLINE CHEM LAB LIMITED has achieved a return of -50.52 %. In the last month alone, the return has been 1.66 %. Read More...

ADLINE CHEM LAB LIMITED fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    7.50

  • P/E Ratio (TTM)

    -19.72

  • Beta

    0.53

  • Book Value / share

    -2.70

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -0.12

info icon alternate text

ADLINE CHEM LAB LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.13
Net Profit -0.12
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.10
Effective Tax Rate (%) 7.69
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.10
Net Profit -0.09
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.07
Effective Tax Rate (%) 10.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.13
Net Profit -0.13
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.10
Effective Tax Rate (%) 7.69
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.06
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.03
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA 0.00
Effective Tax Rate (%) 33.33
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.30
Net Profit -0.27
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.05
EBITDA -0.18
Effective Tax Rate (%) 10.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.88
Net Profit -4.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -7.24
EBITDA -4.14
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.74
Operating Expense 1.39
Net Profit 0.72
Net Profit Margin (%) 97.29
Earnings Per Share (EPS) 1.23
EBITDA 1.08
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 6.33
Operating Expense 7.61
Net Profit -1.28
Net Profit Margin (%) -20.22
Earnings Per Share (EPS) -2.19
EBITDA -0.22
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 6.59
Operating Expense 10.37
Net Profit -3.76
Net Profit Margin (%) -57.05
Earnings Per Share (EPS) -6.45
EBITDA -3.07
Effective Tax Rate (%) -7.40
Particulars MAR 2024 (Values in Cr)
Book Value / Share -2.93
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -2.68
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.45
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.53
ROE % -10.55
ROCE % -7.40
Total Debt to Total Equity 0.83
EBITDA Margin -14.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.30
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.04
EBITDA Margin -3.63
Particulars MAR 2020 (Values in Cr)
Book Value / Share 5.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.81
EBITDA Margin -46.43
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 0.04
Total Liabilities 0.04
Total Equity -1.71
Share Outstanding 5850000
Price to Book Ratio 0.00
Return on Assets (%) -347.38
Return on Capital (%) 63.4
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 0.06
Total Liabilities 0.06
Total Equity -1.56
Share Outstanding 5850000
Price to Book Ratio -2.01
Return on Assets (%) -6858.26
Return on Capital (%) 1806.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 4.87
Total Liabilities 4.87
Total Equity 2.64
Share Outstanding 5850000
Price to Book Ratio 1.45
Return on Assets (%) 14.72
Return on Capital (%) 18.1
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments -0.15
Total Assets 5.63
Total Liabilities 5.63
Total Equity 1.93
Share Outstanding 5850000
Price to Book Ratio 1.55
Return on Assets (%) -22.77
Return on Capital (%) -28.96
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 7.58
Total Liabilities 7.58
Total Equity 3.21
Share Outstanding 5850000
Price to Book Ratio 0.99
Return on Assets (%) -49.63
Return on Capital (%) -62.04
Particulars MAR 2024 (Values in Cr)
Net Income -0.14
Cash from Operations -0.01
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow -0.01
Particulars MAR 2023 (Values in Cr)
Net Income -4.23
Cash from Operations 0.01
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow 0.01
Particulars MAR 2022 (Values in Cr)
Net Income 0.71
Cash from Operations 0.21
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow 0.21
Particulars MAR 2021 (Values in Cr)
Net Income -1.28
Cash from Operations -0.29
Cash from Investing 0.11
Cash from Financing -0.03
Net change in Cash -0.20
Free Cash Flow -0.28
Particulars MAR 2020 (Values in Cr)
Net Income -3.76
Cash from Operations -11.33
Cash from Investing 11.24
Cash from Financing -0.02
Net change in Cash -0.11
Free Cash Flow -11.24
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

ADLINE CHEM LAB LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
12.82 1.98 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 12.00
  • 26 Days 13.60
  • 10 Days 11.80
  • 50 Days 15.60
  • 12 Days 11.90
  • 100 Days 16.90
  • 20 Days 12.80
  • 200 Days 16.30
12.57 PIVOT

First Support

12.57

First Resistance

12.57

Second Support

12.57

Second Resistance

12.57

Third Support

12.57

Third Resistance

12.57

RSI

44.11

ADX

74.12

MACD

-1.69

Williams % R

0.00

Commodity Channel Index (CCI)

33.70

Date

2025-04-29

Week

340.00

Same Day

100.00

Month

267.00

1 Year

0.53

3 Year

0.50

Over 1 Month

1.66%

down

Over 1 Year

-50.52%

down

Over 3 Months

-28.77%

down

Over 3 Years

15.40%

down

Over 6 Months

-49.70%

down

Over 5 Years

20.72%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

ADLINE CHEM LAB LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
70.38%
Promoter Holdings
29.61%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Hemant Amrish Parikh 1512440.0 (25.85%) Shareholding of Promoter and Promoter Group
Jagrutiben J Laskari 53900.0 (0.92%) Shareholding of Promoter and Promoter Group
Balkrishna B Patel 53900.0 (0.92%) Shareholding of Promoter and Promoter Group
Gaurav B Patel 53500.0 (0.91%) Shareholding of Promoter and Promoter Group
Priyanka A Patel 51500.0 (0.88%) Shareholding of Promoter and Promoter Group
Paulomy Lashkari 2500.0 (0.04%) Shareholding of Promoter and Promoter Group
Paulomi Zabal Laskari 2500.0 (0.04%) Shareholding of Promoter and Promoter Group
Kalavatiben Bhagubhai Patel 1000.0 (0.02%) Shareholding of Promoter and Promoter Group
Dineshchandra Bhikhabhai Patel 1000.0 (0.02%) Shareholding of Promoter and Promoter Group
Sohan Kamlesh Laskari 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rohan Kamlesh Laskari 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ranak Kamlesh Laskari 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kamlesh Jagdish Laskari Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ADLINE CHEM LAB LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

ADLINE CHEM LAB LIMITED Share Price

Adline Chem Lab Limited (Formerly known as Kamron Laboratories Limited) was incorporated in 1988 by its Promoter, Mr Kamlesh J Laskari. The Company name was changed from Kamron Laboratories Limited' to Adline Chem Lab Limited effective on October 13, 2021.
The Company is engaged primarily in the business of marketing of Pharmaceutical and Nutraceuticals products.

In May 1990, the Company started production at its site in Rakanpur, Gujarat. Initially, the Company was manufacturing tablets, capsules and liquid orals. In 1993, it started manufacture of injections.

At present, the company is marketing its products in many states of India and also exporting to a few countries. But over the period of last three decades, there were major changes in the manufacturing technology and building layout due to which the company's plant became obsolete. After taking shareholders approval, the company had discontinued the production in 2019 and sold its land and building in December 2019.

Currently the company is continuing the marketing activities and getting its products manufactured from various manufacturers.

Mr. Hemant A. Parikh acquired the shares of the Company via Open Offer process in October, 2023 and has become the Promoter of the Company in 2023-24.

Parent organization Indian Private
NSE symbol [-]
Founded 1988
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Adline Chem Lab Ltd?

Answer Field

The share price of Adline Chem Lab Ltd for NSE is ₹ 0.00 and for BSE is ₹ 12.82.

What is the Market Cap of Adline Chem Lab Ltd?

Answer Field

The market cap of Adline Chem Lab Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 7.50 Cr. as of now.

What is the 52 Week High and Low of Adline Chem Lab Ltd?

Answer Field

The 52 Week High and Low of Adline Chem Lab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 26.01 and ₹ 9.40.

How to Buy Adline Chem Lab Ltd share?

Answer Field

You can trade in Adline Chem Lab Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Adline Chem Lab Ltd?

Answer Field

The 1 year returns on the stock has been -50.52%.

What is the Current Share Price of Adline Chem Lab Ltd?

Answer Field

Adline Chem Lab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 12.82 as on Apr 29 2025 12:00 AM.

What is the Market Cap of Adline Chem Lab Ltd Share?

Answer Field

The market cap of Adline Chem Lab Ltd for NSE ₹ 0.0 & for BSE ₹ 7.50 as on Apr 29 2025 12:00 AM.

What is the P/E Ratio of Adline Chem Lab Ltd Share?

Answer Field

As on Apr 29 2025 12:00 AM the price-to-earnings (PE) ratio for Adline Chem Lab Ltd share is -19.72.

What is the PB ratio of Adline Chem Lab Ltd Share?

Answer Field

As on Apr 29 2025 12:00 AM, the price-to-book (PB) ratio for Adline Chem Lab Ltd share is -2.70.

How to Buy Adline Chem Lab Ltd Share?

Answer Field

You can trade in Adline Chem Lab Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Adline Chem Lab Ltd Share on Bajaj Broking App?

Answer Field

To buy Adline Chem Lab Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Adline Chem Lab Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|